AIBMR Life Sciences
Consulting firm preparing GRAS conclusions, NDI notifications and toxicology and safety assessments.
- LEAD TIME
- Not publicly disclosed
Overview
AIBMR Life Sciences, Inc. is an independent scientific and regulatory consulting firm founded in 1978, serving the dietary supplement, food, and natural products industries. The firm prepares GRAS (Generally Recognized as Safe) independent conclusions and FDA GRAS notifications, New Dietary Ingredient (NDI) notifications, and toxicology and safety assessments, and coordinates expert safety panels. AIBMR has been named as the notifying agent on FDA GRAS notices for dietary ingredients and maintains a public database of independent GRAS conclusions.
Certifications
No certifications on record.
Capabilities
- PRODUCT TYPES
- GRAS Independent Conclusions · FDA GRAS Notifications · NDI Notifications · Toxicology and Safety Assessment · Regulatory Compliance
- CAPABILITIES
- New dietary ingredient (NDI) notifications · GRAS or food-additive filings · Toxicology or safety assessments · Regulatory strategy, submissions or compliance
Sources
What we couldn't verify
We did not visit this company on site. See the limits that apply to every listing.
- Consulting firm, not a manufacturer; provides regulatory and scientific guidance only
- Strongest for GRAS, NDI, and toxicology/safety pre-market pathways rather than facility cGMP audits
- Track-record details are self-reported
Dietary supplement manufacturers must comply with 21 CFR Part 111 (cGMP). What Part 111 requires
The connection map between AIBMR Life Sciences and other vendors, capabilities, and certifications is in the manufacturer atlas.
Enforcement screening: included in Inventory Ready's most recent completed pass against FDA's published recall datasets (2026-07-09). Method and limits →
Our Evaluation Method
A full assessment applies six checks. Source-Checked listings get a lighter review.
- Independent confirmation: Claims backed by documentation, not marketing copy
- How recent the data is: Information reviewed and dated within the last 12 months
- Sources we traced: Sources cited for every key claim
- Inconsistencies flagged: Where a company's claims and public records disagree, we say so
- What we disclose: Material connections stated directly on affected listings
- What we don't know: When we can't assess something, we say so explicitly
Interested in AIBMR Life Sciences?
Tell us about your project and we'll help you determine if this regulatory consultant is a good fit.